Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | HGNC ID | DiseaseId | DiseaseName | Frequency | Onset | HGMD variants | ClinVar variants |
---|
HPO disease - gene - phenotype typical associations: |
HPO disease - gene - phenotype less frequent non-typical associations: |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | ACAT1 CL E G H | 38 | 93 | ORPHA:134 | Beta-ketothiolase deficiency | | | | 91 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | | | | 73 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | ALDOB CL E G H | 229 | 417 | ORPHA:469 | Hereditary fructose intolerance | | | | 73 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | | | | 404 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | CLDN16 CL E G H | 10686 | 2037 | OMIM:248250 | Hypomagnesemia 3, renal | | | | 58 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | CTNS CL E G H | 1497 | 2518 | ORPHA:411634 | Juvenile nephropathic cystinosis | | | | 178 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | DPYS CL E G H | 1807 | 3013 | OMIM:222748 | Dihydropyrimidinuria | | | | 44 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | EHHADH CL E G H | 1962 | 3247 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 2 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | | | | 64 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | | | | | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | GATM CL E G H | 2628 | 4175 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 86 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | GPHN CL E G H | 10243 | 15465 | OMIM:615501 | Molybdenum cofactor deficiency, complementation group C | | | | 18 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | | | | 35 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | | | | 35 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HNF1B CL E G H | 6928 | 11630 | ORPHA:93111 | HNF1B-related autosomal dominant tubulointerstitial kidney disease | | | | 90 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HNF1B CL E G H | 6928 | 11630 | OMIM:137920 | Renal cysts and diabetes syndrome | | | | 90 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HNF4A CL E G H | 3172 | 5024 | OMIM:616026 | Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | | | | 138 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HPRT1 CL E G H | 3251 | 5157 | OMIM:300323 | Gout, hprt-related | | | | 76 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HPRT1 CL E G H | 3251 | 5157 | ORPHA:79233 | Hypoxanthine guanine phosphoribosyltransferase partial deficiency | | | | 76 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HPRT1 CL E G H | 3251 | 5157 | ORPHA:510 | Lesch-Nyhan syndrome | | | | 76 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | HPRT1 CL E G H | 3251 | 5157 | OMIM:300322 | Lesch-Nyhan syndrome | | | | 76 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | LMAN1 CL E G H | 3998 | 6631 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | | | | 56 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | MCFD2 CL E G H | 90411 | 18451 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | | | | 77 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | | | | 4 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | MOCS1 CL E G H | 4337 | 7190 | OMIM:252150 | Molybdenum cofactor deficiency, complementation group A | | | | 96 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | MOCS2 CL E G H | 4338 | 7193 | OMIM:252160 | Molybdenum cofactor deficiency, complementation group B | | | | 26 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | MUC1 CL E G H | 4582 | 7508 | OMIM:174000 | Tubulointerstitial kidney disease, autosomal dominant, 2 | | | | 1 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | MYC CL E G H | 4609 | 7553 | ORPHA:543 | Burkitt lymphoma | | | | 11 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 39 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | OTC CL E G H | 5009 | 8512 | OMIM:311250 | Ornithine transcarbamylase deficiency, hyperammonemia due to | | | | 369 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PFKM CL E G H | 5213 | 8877 | ORPHA:371 | Glycogen storage disease due to muscle phosphofructokinase deficiency | | | | 64 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PFKM CL E G H | 5213 | 8877 | OMIM:232800 | Glycogen storage disease VII | | | | 64 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PHKA2 CL E G H | 5256 | 8926 | OMIM:306000 | Glycogen storage disease ixa | | | | 54 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PHKB CL E G H | 5257 | 8927 | OMIM:261750 | Glycogen storage disease ixb | | | | 101 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PNP CL E G H | 4860 | 7892 | ORPHA:760 | Purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | POLG CL E G H | 5428 | 9179 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 464 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | | | | 42 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | | | | 42 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:1187 | Lethal ataxia with deafness and optic atrophy | | | | 49 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411536 | Mild phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PRPS1 CL E G H | 5631 | 9462 | OMIM:300661 | Phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411543 | Severe phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | PYGM CL E G H | 5837 | 9726 | OMIM:232600 | Glycogen storage disease V | | | | 166 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | REN CL E G H | 5972 | 9958 | OMIM:613092 | Hyperuricemic nephropathy, familial juvenile, 2 | | | | 25 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SARS2 CL E G H | 54938 | 17697 | OMIM:613845 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome | | | | 60 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SEC61A1 CL E G H | 29927 | 18276 | OMIM:617056 | Tubulointerstitial kidney disease, autosomal dominant, 5 | | | | 2 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SH2B1 CL E G H | 25970 | 30417 | ORPHA:261222 | Distal 16p11.2 microdeletion syndrome | | | | | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC22A12 CL E G H | 116085 | 17989 | ORPHA:94088 | Hereditary renal hypouricemia | | | | 56 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | | | | 56 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC2A2 CL E G H | 6514 | 11006 | OMIM:227810 | Fanconi-Bickel syndrome | | | | 71 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC2A9 CL E G H | 56606 | 13446 | ORPHA:94088 | Hereditary renal hypouricemia | | | | 57 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC2A9 CL E G H | 56606 | 13446 | OMIM:612076 | Hypouricemia, renal, 2 | | | | 57 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:3337 | Primary Fanconi renotubular syndrome | | | | 47 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | | | | 110 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | | | | 110 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | | | | 110 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | TNFRSF11A CL E G H | 8792 | 11908 | ORPHA:2801 | Juvenile Paget disease | | | | 72 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | TNFRSF11B CL E G H | 4982 | 11909 | ORPHA:2801 | Juvenile Paget disease | | | | 44 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | TNFRSF11B CL E G H | 4982 | 11909 | OMIM:239000 | Paget disease of bone 5, juvenile-onset | | | | 44 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | TYMP CL E G H | 1890 | 3148 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 138 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | UMOD CL E G H | 7369 | 12559 | OMIM:162000 | Hyperuricemic nephropathy, familial juvenile, 1 | | | | 66 | | |
HP:0010932 | HP:0010932 | Abnormal circulating nucleobase concentration | 0 | XDH CL E G H | 7498 | 12805 | OMIM:278300 | Xanthinuria, type I | | | | 79 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | ACAT1 CL E G H | 38 | 93 | ORPHA:134 | Beta-ketothiolase deficiency | HP:0040281 - Very frequent | | | 91 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | ALDOB CL E G H | 229 | 417 | OMIM:229600 | Fructose intolerance, hereditary | . | | | 73 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | ALDOB CL E G H | 229 | 417 | ORPHA:469 | Hereditary fructose intolerance | HP:0040283 - Occasional | | | 73 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | ALMS1 CL E G H | 7840 | 428 | OMIM:203800 | Alstrom syndrome | . | | | 404 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | ATP7B CL E G H | 540 | 870 | OMIM:277900 | Wilson disease | | | | 315 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | CLDN16 CL E G H | 10686 | 2037 | OMIM:248250 | Hypomagnesemia 3, renal | . | | | 58 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | CTNS CL E G H | 1497 | 2518 | ORPHA:411634 | Juvenile nephropathic cystinosis | HP:0040283 - Occasional | | | 178 | | |
HP:0010932 | HP:0004353 | Abnormal circulating pyrimidine concentration | 1 | DPYS CL E G H | 1807 | 3013 | OMIM:222748 | Dihydropyrimidinuria | | | | 44 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | EHHADH CL E G H | 1962 | 3247 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 2 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | FBP1 CL E G H | 2203 | 3606 | ORPHA:348 | Fructose-1,6-bisphosphatase deficiency | HP:0040282 - Frequent | | | 64 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | G6PC1 CL E G H | 2538 | 4056 | OMIM:232200 | Glycogen storage disease ia | . | | | | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | GATM CL E G H | 2628 | 4175 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 86 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | GPHN CL E G H | 10243 | 15465 | OMIM:615501 | Molybdenum cofactor deficiency, complementation group C | . | | | 18 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HMGCL CL E G H | 3155 | 5005 | ORPHA:20 | 3-hydroxy-3-methylglutaric aciduria | HP:0040282 - Frequent | | | 35 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HMGCL CL E G H | 3155 | 5005 | OMIM:246450 | 3-Hydroxy-3-Methylglutaryl-Coa lyase deficiency | . | | | 35 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HNF1B CL E G H | 6928 | 11630 | ORPHA:93111 | HNF1B-related autosomal dominant tubulointerstitial kidney disease | HP:0040283 - Occasional | | | 90 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HNF1B CL E G H | 6928 | 11630 | OMIM:137920 | Renal cysts and diabetes syndrome | | | | 90 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | HNF4A CL E G H | 3172 | 5024 | OMIM:616026 | Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young | . | | | 138 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HPRT1 CL E G H | 3251 | 5157 | OMIM:300323 | Gout, hprt-related | . | | | 76 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HPRT1 CL E G H | 3251 | 5157 | ORPHA:79233 | Hypoxanthine guanine phosphoribosyltransferase partial deficiency | HP:0040282 - Frequent | | | 76 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HPRT1 CL E G H | 3251 | 5157 | ORPHA:510 | Lesch-Nyhan syndrome | HP:0040281 - Very frequent | | | 76 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | HPRT1 CL E G H | 3251 | 5157 | OMIM:300322 | Lesch-Nyhan syndrome | . | | | 76 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | LMAN1 CL E G H | 3998 | 6631 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | HP:0040284 - Very rare | | | 56 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | MCFD2 CL E G H | 90411 | 18451 | ORPHA:35909 | Combined deficiency of factor V and factor VIII | HP:0040284 - Very rare | | | 77 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | . | | | 4 | | |
HP:0010932 | HP:0004352 | Abnormal circulating purine concentration | 1 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | | | | 4 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | MOCS1 CL E G H | 4337 | 7190 | OMIM:252150 | Molybdenum cofactor deficiency, complementation group A | . | | | 96 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | MOCS2 CL E G H | 4338 | 7193 | OMIM:252160 | Molybdenum cofactor deficiency, complementation group B | . | | | 26 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | MUC1 CL E G H | 4582 | 7508 | OMIM:174000 | Tubulointerstitial kidney disease, autosomal dominant, 2 | . | | | 1 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | MYC CL E G H | 4609 | 7553 | ORPHA:543 | Burkitt lymphoma | HP:0040282 - Frequent | | | 11 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | NDUFAF6 CL E G H | 137682 | 28625 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 39 | | |
HP:0010932 | HP:0004353 | Abnormal circulating pyrimidine concentration | 1 | OTC CL E G H | 5009 | 8512 | OMIM:311250 | Ornithine transcarbamylase deficiency, hyperammonemia due to | | | | 369 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PFKM CL E G H | 5213 | 8877 | ORPHA:371 | Glycogen storage disease due to muscle phosphofructokinase deficiency | HP:0040282 - Frequent | | | 64 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PFKM CL E G H | 5213 | 8877 | OMIM:232800 | Glycogen storage disease VII | . | | | 64 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PHKA2 CL E G H | 5256 | 8926 | OMIM:306000 | Glycogen storage disease ixa | | | | 54 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PHKB CL E G H | 5257 | 8927 | OMIM:261750 | Glycogen storage disease ixb | | | | 101 | | |
HP:0010932 | HP:0004352 | Abnormal circulating purine concentration | 1 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | PNP CL E G H | 4860 | 7892 | ORPHA:760 | Purine nucleoside phosphorylase deficiency | HP:0040282 - Frequent | | | 52 | | |
HP:0010932 | HP:0004353 | Abnormal circulating pyrimidine concentration | 1 | POLG CL E G H | 5428 | 9179 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 464 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PPARG CL E G H | 5468 | 9236 | OMIM:604367 | Lipodystrophy, familial partial, type 3 | . | | | 42 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PPARG CL E G H | 5468 | 9236 | ORPHA:79083 | PPARG-related familial partial lipodystrophy | HP:0040283 - Occasional | | | 42 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:1187 | Lethal ataxia with deafness and optic atrophy | HP:0040282 - Frequent | | | 49 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411536 | Mild phosphoribosylpyrophosphate synthetase superactivity | HP:0040281 - Very frequent | | | 49 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PRPS1 CL E G H | 5631 | 9462 | OMIM:300661 | Phosphoribosylpyrophosphate synthetase superactivity | | | | 49 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PRPS1 CL E G H | 5631 | 9462 | ORPHA:411543 | Severe phosphoribosylpyrophosphate synthetase superactivity | HP:0040281 - Very frequent | | | 49 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | PYGM CL E G H | 5837 | 9726 | OMIM:232600 | Glycogen storage disease V | | | | 166 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | REN CL E G H | 5972 | 9958 | OMIM:613092 | Hyperuricemic nephropathy, familial juvenile, 2 | . | | | 25 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | SARS2 CL E G H | 54938 | 17697 | OMIM:613845 | Hyperuricemia, pulmonary hypertension, renal failure, and alkalosis syndrome | . | | | 60 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | SEC61A1 CL E G H | 29927 | 18276 | OMIM:617056 | Tubulointerstitial kidney disease, autosomal dominant, 5 | . | | | 2 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | SH2B1 CL E G H | 25970 | 30417 | ORPHA:261222 | Distal 16p11.2 microdeletion syndrome | HP:0040282 - Frequent | | | | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | SLC22A12 CL E G H | 116085 | 17989 | ORPHA:94088 | Hereditary renal hypouricemia | HP:0040280 - Obligate | | | 56 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | SLC22A12 CL E G H | 116085 | 17989 | OMIM:220150 | Hypouricemia, renal, 1 | . | | | 56 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | SLC2A2 CL E G H | 6514 | 11006 | OMIM:227810 | Fanconi-Bickel syndrome | . | | | 71 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | SLC2A9 CL E G H | 56606 | 13446 | ORPHA:94088 | Hereditary renal hypouricemia | HP:0040280 - Obligate | | | 57 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | SLC2A9 CL E G H | 56606 | 13446 | OMIM:612076 | Hypouricemia, renal, 2 | | | | 57 | | |
HP:0010932 | HP:0003537 | Hypouricemia | 1 | SLC34A1 CL E G H | 6569 | 11019 | ORPHA:3337 | Primary Fanconi renotubular syndrome | HP:0040282 - Frequent | | | 47 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | SLC37A4 CL E G H | 2542 | 4061 | ORPHA:79259 | Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib | HP:0040281 - Very frequent | | | 110 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232220 | Glycogen storage disease ib | . | | | 110 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | SLC37A4 CL E G H | 2542 | 4061 | OMIM:232240 | GLYCOGEN STORAGE DISEASE Ic | . | | | 110 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | TNFRSF11A CL E G H | 8792 | 11908 | ORPHA:2801 | Juvenile Paget disease | HP:0040281 - Very frequent | | | 72 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | TNFRSF11B CL E G H | 4982 | 11909 | ORPHA:2801 | Juvenile Paget disease | HP:0040281 - Very frequent | | | 44 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | TNFRSF11B CL E G H | 4982 | 11909 | OMIM:239000 | Paget disease of bone 5, juvenile-onset | . | | | 44 | | |
HP:0010932 | HP:0004353 | Abnormal circulating pyrimidine concentration | 1 | TYMP CL E G H | 1890 | 3148 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 138 | | |
HP:0010932 | HP:0002149 | Hyperuricemia | 1 | UMOD CL E G H | 7369 | 12559 | OMIM:162000 | Hyperuricemic nephropathy, familial juvenile, 1 | . | | | 66 | | |
HP:0010932 | HP:0004352 | Abnormal circulating purine concentration | 1 | XDH CL E G H | 7498 | 12805 | OMIM:278300 | Xanthinuria, type I | | | | 79 | | |
HP:0010932 | HP:0004369 | Decreased circulating purine concentration | 2 | CL E G H | | | | | | | | | | |
HP:0010932 | HP:0033139 | Elevated circulating uracil concentration | 2 | DPYS CL E G H | 1807 | 3013 | OMIM:222748 | Dihydropyrimidinuria | | | | 44 | | |
HP:0010932 | HP:0004368 | Increased circulating purine concentration | 2 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | | | | 4 | | |
HP:0010932 | HP:0033139 | Elevated circulating uracil concentration | 2 | OTC CL E G H | 5009 | 8512 | OMIM:311250 | Ornithine transcarbamylase deficiency, hyperammonemia due to | | | | 369 | | |
HP:0010932 | HP:0004368 | Increased circulating purine concentration | 2 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0034276 | Elevated circulating thymidine concentration | 2 | POLG CL E G H | 5428 | 9179 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 464 | | |
HP:0010932 | HP:0034277 | Elevated circulating deoxyuridine concentration | 2 | POLG CL E G H | 5428 | 9179 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 464 | | |
HP:0010932 | HP:0034277 | Elevated circulating deoxyuridine concentration | 2 | TYMP CL E G H | 1890 | 3148 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 138 | | |
HP:0010932 | HP:0034276 | Elevated circulating thymidine concentration | 2 | TYMP CL E G H | 1890 | 3148 | OMIM:603041 | Mitochondrial DNA depletion syndrome 1 (mngie type) | | | | 138 | | |
HP:0010932 | HP:0004368 | Increased circulating purine concentration | 2 | XDH CL E G H | 7498 | 12805 | OMIM:278300 | Xanthinuria, type I | | | | 79 | | |
HP:0010932 | HP:0034333 | Increased circulating hypoxanthine concentration | 3 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | | | | 4 | | |
HP:0010932 | HP:0010933 | Hyperxanthinemia | 3 | MOCOS CL E G H | 55034 | 18234 | OMIM:603592 | Xanthinuria, type II | | | | 4 | | |
HP:0010932 | HP:0033340 | Increased circulating guanosine concentration | 3 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0033339 | Increased circulating inosine concentration | 3 | PNP CL E G H | 4860 | 7892 | OMIM:613179 | Immunodeficiency due to purine nucleoside phosphorylase deficiency | | | | 52 | | |
HP:0010932 | HP:0010933 | Hyperxanthinemia | 3 | XDH CL E G H | 7498 | 12805 | OMIM:278300 | Xanthinuria, type I | | | | 79 | | |